Search Results

By Richard A. Brodkin, MD  / April 25, 2017

More on Treatment Decisions in Esophageal Cancer

In the March 25, 2017, issue of The ASCO Post, Steven H. Lin, MD, PhD, shared his thoughts on the role of positron-emission tomography (PET) in assessing response to induction chemotherapy in patients with resectable esophageal or gastroesophageal junction cancer. He noted that complete pathologic...